In 2009, Tulane University researchers received a five-year $7,073,538 grant from the National Institute of Health to fund the continued development of detection kits for Lassa viral hemorrhagic fever. Since then researchers from Tulane University (TU) have been active in the exact areas in Afrika where this present Ebola (2014) outbreak is occurring. iThese researchers are working with other institutions, in particular the US Army Medical Research Institute of Infectious Diseases USAMRIID, a well-known center for biowar research, located at Fort Detrick, Maryland. What exactly have they been doing? Exactly what diagnostic tests have they been performing on citizens of Sierra Leone?
Has Tulane researchers and their associates attempted any experimental treatments (e.g., injecting monoclonal antibodies) using citizens of the region? If so, what adverse events have occurred? We have reports that the government of Sierra Leone has recently told Tulane researchers to stop this testing?
The research program, occurring in Sierra Leone, the Republic of Guinea, and Liberia—said to be the epicenter of this most recent Ebola outbreak (2014)—has the announced purpose, among others, of detecting the future use of fever-viruses as bioweapons. In Sierra Leone, the Tulane group has been researching new diagnostic tests for hemorrhagic fevers. Dr. Robert Garry, Professor of Microbiology and Immunology, and Dr. James Robinson, Professor of Pediatrics, have been involved in the research of Lassa fever. Together the two have recently been able to create what are called human monoclonal antibodies. After isolating the B-cells from patients that have survived the disease, they have utilized molecular cloning methods to isolate the antibodies and reproduce them in the laboratory. These antibodies have been tested on guinea pigs at The University of Texas Medical Branch in Galveston and shown to help prevent them from dying of Lassa fever…
Lassa fever is part of the family of Viral Hemorrhaging Diseases (VHD), which includes Ebola, and others diseases. So, in other words TU has been testing using virus that are part of the Ebola family! According to Tulane University press, the researchers have also been investigating the use of monoclonal antibodies as a treatment for these fevers—but supposedly not on-site in Afrika,
It has been claimed that the testing is purely for defensive purposes. In 2007, TU announced it had developed new test to moves forward the detection of bioterrorism threats. “The initial round of clinical testing has been completed for the first diagnostic test kits that will aid in bioterrorism defense against a deadly viral disease. Tulane University researchers are collaborating in the project. But my question is this purely defensive research, or as we have seen in the past, is this research being covertly used to develop offensive bioweapons? Is this germ warfare or a case of testing gone wrong?